Drew Armstrong ✓

@ArmstrongDrew · NYC · joined 23 Oct 2009

Executive Editor, Endpoints News (@endpts). Got a confidential tip? Message me on Signal: DrewArmstrong.39

28 936Followers

3 068Following

9 966Posts total

13.2KViews on collected posts

Postingan terbaru

Drew Armstrong ✓@ArmstrongDrew22 Sep

📢We're hiring! Endpoints is looking for our next great FDA reporter, somebody who wants to write scoops of news and idea and the intersection of policy, science and companies. If that's you... apply! https://t.co/8uSQkSWjWo 2.1K views · 10 likes · 4 reposts · 1 replies Open on X →

Drew Armstrong ✓@ArmstrongDrew21 Sep

@ArmstrongDrew @Public_Citizen But it’s a PBM problem @mcuban ? 49 views · 0 likes · 0 reposts · 0 replies Open on X →

Drew Armstrong ✓@ArmstrongDrew21 Sep

The Trump admin MFN deals have a very interesting component: Pfizer (and probably Lilly, and maybe Merck?) will have to share revenue from raised prices outside the US. $PFE $LLY $MRK https://t.co/qx0bdOTLdf 1.6K views · 6 likes · 1 reposts · 2 replies Open on X →

Drew Armstrong ✓@ArmstrongDrew21 Sep

Love to send an email and have the reply come on X, but @KushDesai47 fairly points out that this detail has been public for a while. (Looking forward to @maxonwifi's return) 5.8K views · 6 likes · 0 reposts · 1 replies Open on X →

Drew Armstrong ✓@ArmstrongDrew21 Sep

Lilly's agreement has a similarly named section, but is more heavily redacted: https://t.co/xukeR0BD9j

1.3K views · 3 likes · 1 reposts · 0 replies Open on X →

Drew Armstrong ✓@ArmstrongDrew16 Sep

We sold out so early, our events team made me stop posting about this. But the @endpts China debate (round 2!) in DC last night was a hit. Great to see so many from gov + biz joining for what we think is among the most important stories in biotech right now. See you next time!

2.2K views · 12 likes · 1 reposts · 1 replies Open on X →

Dibandingkan akun berukuran sama

6 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. tampil luas, tetapi sedikit penonton yang merespons.

Median tayangan1 895akun ini924median untuk 10K–100K

Jangkauan, %6.55%akun ini3.62%median untuk 10K–100K

Interaksi, %0.42%akun ini1.52%median untuk 10K–100K

Metrik	Akun ini	Median untuk 10K–100K	Rasio
Median tayangan per postingan	1 895	924	2.05×
Jangkauan (tayangan ÷ pengikut)	6.55%	3.62%	1.81×
Tingkat interaksi	0.42%	1.52%	0.28×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.2K16 Sep

1.3K21 Sep

5.8K

1.6K

2.1K22 Sep

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.64%16 Sep

0.30%21 Sep

0.12%

0.55%

0.00%

0.70%22 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes68.5%37 in total

Reposts13.0%7 in total

Replies9.3%5 in total

Bookmarks9.3%5 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Postingan terbaru

Dibandingkan akun berukuran sama

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Akun serupa